Dawn Terashita
- Infectious Diseases top 10%
- Epidemiology
- Molecular Medicine top 5%
- Molecular Biology
- Clinical Biochemistry top 10%
- Co-authors
- Sharon BalterPatricia MárquezLaurene MascolaDavid E. DasseyJamie ChangNava YeganehZachary RubinRamon E. Guevara
- Topics
- Antibiotic Resistance in Bacteria (7 papers)Antibiotic Use and Resistance (6 papers)Bacillus and Francisella bacterial research (4 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Dawn Terashita
43 papers receiving 537 citations
Peers
Comparison fields: 5 of 99
- Infectious Diseases 184
- Epidemiology 162
- Molecular Medicine 106
- Molecular Biology 64
- Clinical Biochemistry 63
Countries citing papers authored by Dawn Terashita
This map shows the geographic impact of Dawn Terashita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Terashita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Terashita more than expected).
Fields of papers citing papers by Dawn Terashita
This network shows the impact of papers produced by Dawn Terashita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Terashita. The network helps show where Dawn Terashita may publish in the future.
Co-authorship network of co-authors of Dawn Terashita
This figure shows the co-authorship network connecting the top 25 collaborators of Dawn Terashita. A scholar is included among the top collaborators of Dawn Terashita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn Terashita. Dawn Terashita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 7 | |
| 3 | 19 | |
| 4 | 8 | |
| 5 | 55 | |
| 6 | 3 | |
| 7 | 34 | |
| 8 | 22 | |
| 9 | 16 | |
| 10 | 14 | |
| 11 | Coccidioidomycosis among cast and crew members at an outdoor television filming event--California, 2012. | 19 |
| 12 | 14 | |
| 13 | 13 | |
| 14 | 34 | |
| 15 | The Clinician's Role in Identifying Legionella | 1 |
| 16 | 10 | |
| 17 | 1 | |
| 18 | 50 | |
| 19 | 1 | |
| 20 | 23 |
About Dawn Terashita
Dawn Terashita is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Endocrinology, having authored 44 papers that have together received 555 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Antibiotic Use and Resistance (6 papers) and Bacillus and Francisella bacterial research (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (50 citations), Molecular Medicine (106 citations) and Infectious Diseases (184 citations). Dawn Terashita has collaborated with scholars based in United States and Canada. Frequent co-authors include Sharon Balter, Patricia Márquez, Laurene Mascola, David E. Dassey, Jamie Chang, Nava Yeganeh, Zachary Rubin, Ramon E. Guevara, Elizabeth Bancroft and Maria Palmieri. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and American Journal of Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.